Wire News
Genetics of imatinib resistance in acute lymphoblastic leukemia
In the Sept. 15 issue of Genes & Development, scientists lend new insights into how an aggressive form of acute lymphoblastic leukemia develops, and how sensitivity to the targeted chemotherapeutic drug, imatinib, can be diminished through interactions be ...
Source:
Cold Spring Harbor Laboratory
Wednesday, August 29, 2007